BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22613533)

  • 21. [Effects of allitridum on rapidly delayed rectifier potassium current in HEK293 cell line].
    Zhang J; Lin K; Wei Z; Chen Q; Liu L; Zhao X; Zhao Y; Xu B; Chen X; Li Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Aug; 35(8):1128-32, 1142. PubMed ID: 26277508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allocryptopine and benzyltetrahydropalmatine block hERG potassium channels expressed in HEK293 cells.
    Lin K; Liu YQ; Xu B; Gao JL; Fu YC; Chen Y; Xue Q; Li Y
    Acta Pharmacol Sin; 2013 Jun; 34(6):847-58. PubMed ID: 23524574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclovirobuxine D inhibits the currents of HERG potassium channels stably expressed in HEK293 cells.
    Zhao J; Wang Q; Xu J; Zhao J; Liu G; Peng S
    Eur J Pharmacol; 2011 Jun; 660(2-3):259-67. PubMed ID: 21497594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of sophocarpine on HERG K+ channels].
    Qi ZP; Shi SS; Zhao XL; Zhao WX; Bai YL; Lü YJ; Li BX; Yang BF
    Yao Xue Xue Bao; 2008 Jan; 43(1):44-9. PubMed ID: 18357730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiologic characterization of a novel hERG channel activator.
    Su Z; Limberis J; Souers A; Kym P; Mikhail A; Houseman K; Diaz G; Liu X; Martin RL; Cox BF; Gintant GA
    Biochem Pharmacol; 2009 Apr; 77(8):1383-90. PubMed ID: 19426677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mechanism for the potential proarrhythmic effect of acidosis, bradycardia, and hypokalemia on the blockade of human ether-a-go-go-related gene (HERG) channels.
    Lin C; Cvetanovic I; Ke X; Ranade V; Somberg J
    Am J Ther; 2005; 12(4):328-36. PubMed ID: 16041196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV Tat protein inhibits hERG K+ channels: a potential mechanism of HIV infection induced LQTs.
    Bai YL; Liu HB; Sun B; Zhang Y; Li Q; Hu CW; Zhu JX; Gong DM; Teng X; Zhang Q; Yang BF; Dong DL
    J Mol Cell Cardiol; 2011 Nov; 51(5):876-80. PubMed ID: 21820442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of cloned hERG potassium channels by risperidone and paliperidone.
    Lee HJ; Choi JS; Choi BH; Hahn SJ
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):633-642. PubMed ID: 28265686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfection by eukaryotic expression vector pcDNA3-HERG inhibits the cultured neonatal rabbit ventricular myocyte hypertrophy induced by phenylephrine.
    Zhao Y; Xu Y; Cui C; Li Y; Zeng Y
    Cardiovasc Pathol; 2012; 21(4):339-45. PubMed ID: 22100990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel.
    Ridley JM; Milnes JT; Hancox JC; Witchel HJ
    J Mol Cell Cardiol; 2006 Jan; 40(1):107-18. PubMed ID: 16288909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The action of the novel gastrointestinal prokinetic prucalopride on the HERG K+ channel and the common T897 polymorph.
    Chapman H; Pasternack M
    Eur J Pharmacol; 2007 Jan; 554(2-3):98-105. PubMed ID: 17109852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Block of hERG K+ channel and prolongation of action potential duration by fluphenazine at submicromolar concentration.
    Hong HK; Lee BH; Park MH; Lee SH; Chu D; Kim WJ; Choe H; Hee Choi B; Jo SH
    Eur J Pharmacol; 2013 Feb; 702(1-3):165-73. PubMed ID: 23395964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anesthetic drug midazolam inhibits cardiac human ether-à-go-go-related gene channels: mode of action.
    Vonderlin N; Fischer F; Zitron E; Seyler C; Scherer D; Thomas D; Katus HA; Scholz EP
    Drug Des Devel Ther; 2015; 9():867-77. PubMed ID: 25733807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
    Kang J; Chen XL; Wang H; Ji J; Cheng H; Incardona J; Reynolds W; Viviani F; Tabart M; Rampe D
    Mol Pharmacol; 2005 Mar; 67(3):827-36. PubMed ID: 15548764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct block of hERG potassium channels by the protein kinase C inhibitor bisindolylmaleimide I (GF109203X).
    Thomas D; Hammerling BC; Wimmer AB; Wu K; Ficker E; Kuryshev YA; Scherer D; Kiehn J; Katus HA; Schoels W; Karle CA
    Cardiovasc Res; 2004 Dec; 64(3):467-76. PubMed ID: 15537500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluconazole inhibits hERG K(+) channel by direct block and disruption of protein trafficking.
    Han S; Zhang Y; Chen Q; Duan Y; Zheng T; Hu X; Zhang Z; Zhang L
    Eur J Pharmacol; 2011 Jan; 650(1):138-44. PubMed ID: 20951697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade of human HERG K⁺ channels by rosiglitazone, an antidiabetic drug.
    Lee SH; Sung MJ; Hahn SJ; Kim J; Min G; Jo SH; Choe H; Choi BH
    Arch Pharm Res; 2012 Sep; 35(9):1655-64. PubMed ID: 23054723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents.
    Katchman AN; McGroary KA; Kilborn MJ; Kornick CA; Manfredi PL; Woosley RL; Ebert SN
    J Pharmacol Exp Ther; 2002 Nov; 303(2):688-94. PubMed ID: 12388652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Papaverine, a vasodilator, blocks the pore of the HERG channel at submicromolar concentration.
    Kim YJ; Hong HK; Lee HS; Moh SH; Park JC; Jo SH; Choe H
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):485-93. PubMed ID: 19034039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade of hERG K(+) channel by antimalarial drug, primaquine.
    Kim KS; Lee HA; Cha SW; Kwon MS; Kim EJ
    Arch Pharm Res; 2010 May; 33(5):769-73. PubMed ID: 20512476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.